|
CDKN2AIPNL expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.45101766344669E-13 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.0883073875998E-12 |
| Normal-vs-Stage2 |
7.986200E-01 |
| Normal-vs-Stage3 |
3.29225535722344E-12 |
| Normal-vs-Stage4 |
1.62458935193399E-12 |
| Stage1-vs-Stage2 |
1.119050E-03 |
| Stage1-vs-Stage3 |
1.319760E-01 |
| Stage1-vs-Stage4 |
1.448980E-04 |
| Stage2-vs-Stage3 |
2.151900E-04 |
| Stage2-vs-Stage4 |
1.97660000000877E-06 |
| Stage3-vs-Stage4 |
5.247600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.05582209641852E-13 |
| Normal-vs-AfricanAmerican |
3.0579999998892E-07 |
| Normal-vs-Asian |
2.30250263300036E-11 |
| Caucasian-vs-AfricanAmerican |
7.527800E-01 |
| Caucasian-vs-Asian |
5.685800E-01 |
| AfricanAmerican-vs-Asian |
9.921000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.34700028908696E-10 |
| Normal-vs-Female |
3.09352543581554E-12 |
| Male-vs-Female |
6.369800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.90991666926266E-12 |
| Normal-vs-Age(41-60Yrs) |
1.17679976874285E-10 |
| Normal-vs-Age(61-80Yrs) |
1.27400000005107E-06 |
| Normal-vs-Age(81-100Yrs) |
1.559250E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.692200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.083590E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.536200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.543400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.346400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.975400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.370500E-04 |
| Classical-VS-Follicular |
9.60159999952026E-07 |
| Classical-VS-Other |
8.550600E-01 |
| Classical-VS-Normal |
1.63158375698913E-12 |
| Tall-VS-Follicular |
7.42830241762249E-11 |
| Tall-VS-Other |
2.705000E-01 |
| Tall-VS-Normal |
1.62458935193399E-12 |
| Follicular-VS-Other |
1.626950E-01 |
| Follicular-VS-Normal |
1.166570E-01 |
| Other-VS-Normal |
5.290500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.22240000016905E-07 |
| Normal-vs-N1 |
2.17603712826531E-14 |
| N0-vs-N1 |
2.02849999999533E-05 |
|
|
